🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Bo Huang

Pfizer (United States)

ORCID: 0000-0002-3088-9328
MathematicsMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: Association between neutrophil-to-eosinophil ratio and efficacy outcomes with avelumab plus axitinib or sunitinib in patients with advanced renal cell carcinoma: post hoc analyses from the JAVELIN Renal 101 trial.

8 citations

Yu‐Wei Chen, Martin H. Voss, Bradley A. McGregor, Mehmet Asım Bilen, Marc‐Oliver Grimm +9 more

10 citations

Timothy A. Lin, Dor Reuven Dabush, Zachary R. McCaw, Alex Koong, Christine Lin +19 more

112 citations

Hua Jin, Hajime Uno, Ying Lü, Bo Huang, Keaven M. Anderson +2 more

1 citations

Bo Huang, Gaohong Dong, Ryuji Uozumi, Lü Tian, Ying Cui

0 citations

Bo Huang, Gaohong Dong, Ryuji Uozumi, Lü Tian, Ying Cui

3 citations

Bo Huang, Lu Mao, Hajime Uno, L. J. Wei, Lü Tian +1 more

78 citations

Lu Mao, Bo Huang, Margaret Gamalo, Jiuzhou Wang, Guanglei Yu +2 more